![EMJ Neurology 8 [Supplement 2] 2020 Front Cover](https://emj.emg-health.com/wp-content/uploads/sites/2/2020/12/EMJ-Neurology-8-Supplement-2-2020-Front-Cover.jpg)
In this supplement to EMJ Neurology, two leading experts in multiple sclerosis (MS), Prof Tjalf Ziemssen and Prof Diego Centonze, explored the sphingosine 1-phosphate (S1P) receptor modulators drug class and how they can be utilised in the management of patients with MS.
Login to continue
Members
Create Account
Create your own personal healthcare feed, full of the latest content from across our divisions.
Register
